News Archive

2020

December

Media Release / Dec 07, 2020

Novartis and Amgen partner with Karamo Brown to support and empower people living with migraine

Read More
Media Release / Dec 01, 2020

Novartis announces FDA approval of Xolair® (omalizumab) for adults with nasal polyps

Read More

November

Media Release / Nov 19, 2020

New data at ASH to reinforce breadth of Novartis hematology portfolio across multiple blood cancers and serious hematologic diseases

Read More
Media Release / Nov 13, 2020

New Novartis analyses for investigational inclisiran demonstrate consistently effective and sustained LDL-C reduction at month 17, regardless of age and gender

Read More
Media Release / Nov 05, 2020

Novartis Cosentyx® shows early synovitis reduction in patients with psoriatic arthritis in first-of-its-kind study

Read More

October

Media Release / Oct 05, 2020

Novartis STEP Program™ awards nearly $375,000 to patient advocacy organizations for their innovative solutions in biomarker testing; now accepting proposals for caregiving in cancer and certain blood disorders

Read More
Media Release / Oct 03, 2020

Novartis announces five-year data that reinforce the safety and efficacy profile of Aimovig® (erenumab-aooe) in adult patients with episodic migraine

Read More

September

Media Release / Sep 16, 2020

Novartis US Foundation commits $25M to improve health equity by reducing health disparities in the US

Read More
Media Release / Sep 11, 2020

Novartis presents data at ACTRIMS-ECTRIMS on the effects of treatment with Mayzent® (siponimod) studied on disability progression and cognitive processing speed in patients with progressing relapsing multiple sclerosis

Read More
Media Release / Sep 11, 2020

Novartis presents data at ACTRIMS-ECTRIMS for Kesimpta® (ofatumumab) in newly diagnosed treatment-naïve adults with relapsing multiple sclerosis

Read More

Related Links